Aromatase inhibitors - Where are we now?

被引：35

作者：

Miller, WR

机构：

来源：

BRITISH JOURNAL OF CANCER | 1996年 / 73卷 / 04期

关键词：

D O I：

10.1038/bjc.1996.73

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：415 / 417

页数：3

共 21 条

[11]

JOHNSTON SRD, 1994, CANCER RES, V54, P5875

[12]

LIPTON A, 1995, CANCER, V75, P2132, DOI 10.1002/1097-0142(19950415)75:8<2132::AID-CNCR2820750816>3.0.CO

[13]

2-U

[14] AMINOGLUTETHIMIDE ENZYME-INDUCTION - PHARMACOLOGICAL AND ENDOCRINOLOGIC IMPLICATIONS [J].

LONNING, PE .

CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1990, 26 (04) :241-244

[15] AROMATASE INHIBITOR DEVELOPMENT FOR TREATMENT OF BREAST-CANCER [J].

MASAMURA, S ;

ADLERCREUTZ, H ;

HARVEY, H ;

LIPTON, A ;

DEMERS, LM ;

SANTEN, RJ ;

SANTNER, SJ .

BREAST CANCER RESEARCH AND TREATMENT, 1995, 33 (01) :19-26

[16] AROMATASE INHIBITORS IN THE TREATMENT OF ADVANCED BREAST-CANCER [J].

MILLER, WR .

CANCER TREATMENT REVIEWS, 1989, 16 (02) :83-93

[17] ENDOCRINE TREATMENT FOR BREAST CANCERS - BIOLOGICAL RATIONALE AND CURRENT PROGRESS [J].

MILLER, WR .

JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1990, 37 (04) :467-480

[18]

SMITH IE, 1982, CANCER RES, V42, P3430

[19] TAMOXIFEN VERSUS AMINOGLUTETHIMIDE IN ADVANCED BREAST-CARCINOMA - A RANDOMIZED CROSSOVER TRIAL [J].

SMITH, IE ;

HARRIS, AL ;

MORGAN, M ;

FORD, HT ;

GAZET, JC ;

HARMER, C ;

WHITE, H ;

PARSONS, CA ;

VILLARDO, A ;

WALSH, G ;

MCKINNA, JA .

BRITISH MEDICAL JOURNAL, 1981, 283 (6304) :1432-1434

[20]

SMITH IE, 1994, ADV CLIN ONCOL, V2, P179

← 1 2 3 →